Peter Attia· MD
I can clear a April be furthers by stopping cholesterol absorption back into the liver any intestine with ezetimibe that does nothing to cholesterol synthesis a pcsk9 inhibitor
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I can clear a April be furthers by stopping cholesterol absorption back into the liver any intestine with ezetimibe that does nothing to cholesterol synthesis a pcsk9 inhibitor
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
then you have Zam now Zam is relatively inexpensive um it's just not as potent so aedm also effectively serves to increase the LDL receptors on the liver but it does so by impairing cholesterol reabsorption so it blocks one of those two Transporters I was talking about in the gut the first one and by blocking that the body is absorbing way less of its own cholesterol and the liver Sensi says that and the liver says hey I got to get more cholesterol puts more LDL receptors on pulls it out of circulation